Biojapan_ics from Twitter

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Nextblockbuster

Rank: President [?]

Points: 2717 [?]

Votes: 15 Score: 3.8 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Biojapan_ics from Twitter

posted on Jan 21, 2017 12:43PM

Advancing Can-Japan partnerships in #cancer #immunotherapy @BioJapan_ICS. Full house for #telestatherapeutics #zenithepigenetics seminar.

looks like Zenith Epigenetics presented in Japan at a seminar promoting Canadian Japanese biotech partnerships in October 2016